TNYA
Price:
$0.8182
Market Cap:
$136.32M
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regene...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
TNYA
According to Tenaya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.75. This represents a change of -0.90% compared to the average of 5.81 of the last 4 quarters.
The mean historical Current Ratio of Tenaya Therapeutics, Inc. over the last ten years is 9.74. The current 5.75 Current Ratio has changed 5.81% with respect to the historical average. Over the past ten years (40 quarters), TNYA's Current Ratio was at its highest in in the December 2020 quarter at 25.78. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
9.74
Median
6.84
Minimum
4.22
Maximum
25.78
Discovering the peaks and valleys of Tenaya Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 282.88%
Maximum Annual Current Ratio = 25.78
Minimum Annual Increase = -54.51%
Minimum Annual Current Ratio = 4.22
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 6.84 | 62.19% |
| 2024 | 4.22 | -14.07% |
| 2023 | 4.91 | -38.57% |
| 2022 | 7.99 | -31.87% |
| 2021 | 11.73 | -54.51% |
| 2020 | 25.78 | 282.88% |
The current Current Ratio of Tenaya Therapeutics, Inc. (TNYA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.32
5-year avg
7.14
10-year avg
9.74
Tenaya Therapeutics, Inc.’s Current Ratio is less than Caribou Biosciences, Inc. (6.22), greater than Enanta Pharmaceuticals, Inc. (3.84), greater than Pyxis Oncology, Inc. (2.76), less than Nautilus Biotechnolgy, Inc. (11.85), less than Immuneering Corporation (32.45), greater than Foghorn Therapeutics Inc. (2.92), less than Abeona Therapeutics Inc. (5.89), greater than Humacyte, Inc. (3.93), greater than Prelude Therapeutics Incorporated (2.03), less than Voyager Therapeutics, Inc. (8.42),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.22 | $160.67M | |
| 3.84 | $305.53M | |
| 2.76 | $142.55M | |
| 11.85 | $214.76M | |
| 32.45 | $155.74M | |
| 2.92 | $304.73M | |
| 5.89 | $369.33M | |
| 3.93 | $110.24M | |
| 2.03 | $231.15M | |
| 8.42 | $184.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenaya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tenaya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tenaya Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tenaya Therapeutics, Inc. (TNYA)?
What is the highest Current Ratio for Tenaya Therapeutics, Inc. (TNYA)?
What is the 3-year average Current Ratio for Tenaya Therapeutics, Inc. (TNYA)?
What is the 5-year average Current Ratio for Tenaya Therapeutics, Inc. (TNYA)?
How does the current Current Ratio for Tenaya Therapeutics, Inc. (TNYA) compare to its historical average?